Sjs Investment Consulting Inc. Bausch Health Companies Inc. Transaction History
Sjs Investment Consulting Inc.
- $647 Million
- Q3 2025
A detailed history of Sjs Investment Consulting Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 30 shares of BHC stock, worth $202. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 30
-0.0%
Holding current value
$202
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
254Shares Held
240MCall Options Held
2.46MPut Options Held
8.42M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$234 Million2.99% of portfolio
-
Goldentree Asset Management LP New York, NY34.3MShares$231 Million23.91% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny32.8MShares$221 Million11.35% of portfolio
-
Nomura Holdings Inc Tokyo, M021.5MShares$145 Million0.31% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$87.6 Million0.18% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.44B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...